Import of Botox Suspended for Six Months

The Korea Food and Drug Administration (KFDA) recently reported its administrative disposition to temporarily halt the import of U.S. Allergan Inc.'s Botox (clostridium botulinum toxin type A) by Daewoong Pharmaceutical for a trade suspension period of six months, starting mid-December.

The decision by the KFDA was based on the Korea Pharmaceutical Affairs Law, where it mandates the pharmace...